✦ LIBER ✦

PCN5 COST-UTILITY ANALYSIS OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (EBC): A UK NATIONAL HEALTH SERVICE (NHS) PERSPECTIVE

✍ Scribed by R Brown; A Benedict; RE Mansel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN4 COST-EFFECTIVENESS OF ANASTROZOLE VS

✍ Benedict Á 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Cost-effectiveness of anastrozole vs tam

✍ R.E Mansel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Cost utility analysis of early adjuvant

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

PCN14 AN ECONOMIC EVALUATION OF ANASTROZ

✍ SV Sorensen; GY Locker 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

PCN116 A SURVIVAL BASED COST-EFFECTIVENE

✍ K El Ouagari; S Kaura; JD Karnon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCN32 COST-EFFECTIVENESS ANALYSIS OF LET

✍ J Karnon; TE Delea; NL Papo; V Barghout; SK Thomas; SR Johnston 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB